Listed

DarioHealth Corp.

DRIONasdaqCIK 1533998HealthcareFiscal year ends Dec 31

Latest reported revenue, Q2 FY2026$5.2mRevenue, Q2 FY2026, three months to 2026-06-30$5.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-11, accession 0001104659-26-093645.Report this figureThree months to Jun 30, 2026, from the 10-Q filed Aug 11, 2026.

Latest quarter: Q2 FY2026

Three months to Jun 30, 2026, against the same quarter a year earlier.

  • Revenue$5.2mRevenue, Q2 FY2026, three months to 2026-06-30$5.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-11, accession 0001104659-26-093645.Report this figure−3.6% on a year earlier
  • Gross margin61.7%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $3.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-11, accession 0001104659-26-093645.Revenue: $5.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-11, accession 0001104659-26-093645.Report this figure+6.5 pts on a year earlier
  • Operating margin−125.1%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$6.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001104659-26-093645.Revenue: $5.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-11, accession 0001104659-26-093645.Report this figure+46.2 pts on a year earlier
  • Net margin−153.1%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: −$7.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001104659-26-093645.Revenue: $5.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-11, accession 0001104659-26-093645.Report this figure+88.9 pts on a year earlier
  • Diluted EPS$0.85Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.85 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001104659-26-093645.Report this figure−76.0% on a year earlier
  • Free cash flow−$6.1mFree cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: −$6.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001104659-26-093645. Derived: 6-month figure less the 3-month figure.Capital expenditure: $38.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-11, accession 0001104659-26-093645. Derived: 6-month figure less the 3-month figure.Report this figure−0.8% on a year earlier

Last eight quarters

Full statements
Revenue$5.2mGross margin 61.7%
Diluted EPS$0.85, Q2 FY2026
Free cash flow−$6.1m, Q2 FY2026
DarioHealth Corp., key figures for the last eight quarters
Line itemUnitQ3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Shape over the periods
Revenue$k7,423Revenue, Q3 FY2024, three months to 2024-09-30$7.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-13, accession 0001104659-25-110730.Report this figure7,604Revenue, Q4 FY2024, three months to 2024-12-31$7.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-03-19, accession 0001104659-26-031621. Derived: 12-month figure less the 9-month figure.Report this figure6,752Revenue, Q1 FY2025, three months to 2025-03-31$6.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-13, accession 0001104659-26-059676.Report this figure5,369Revenue, Q2 FY2025, three months to 2025-06-30$5.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-11, accession 0001104659-26-093645.Report this figure5,007Revenue, Q3 FY2025, three months to 2025-09-30$5.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-13, accession 0001104659-25-110730.Report this figure5,231Revenue, Q4 FY2025, three months to 2025-12-31$5.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-03-19, accession 0001104659-26-031621. Derived: 12-month figure less the 9-month figure.Report this figure5,584Revenue, Q1 FY2026, three months to 2026-03-31$5.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-13, accession 0001104659-26-059676.Report this figure5,177Revenue, Q2 FY2026, three months to 2026-06-30$5.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-11, accession 0001104659-26-093645.Report this figure
Gross margin%52.2%Gross margin, Q3 FY2024, three months to 2024-09-30. gross profit / revenueGross profit: $3.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-13, accession 0001104659-25-110730.Revenue: $7.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-13, accession 0001104659-25-110730.Report this figure55.3%Gross margin, Q4 FY2024, three months to 2024-12-31. gross profit / revenueGross profit: $4.2m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-19, accession 0001104659-26-031621. Derived: 12-month figure less the 9-month figure.Revenue: $7.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-03-19, accession 0001104659-26-031621. Derived: 12-month figure less the 9-month figure.Report this figure57.5%Gross margin, Q1 FY2025, three months to 2025-03-31. gross profit / revenueGross profit: $3.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-13, accession 0001104659-26-059676.Revenue: $6.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-13, accession 0001104659-26-059676.Report this figure55.2%Gross margin, Q2 FY2025, three months to 2025-06-30. gross profit / revenueGross profit: $3.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-11, accession 0001104659-26-093645.Revenue: $5.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-11, accession 0001104659-26-093645.Report this figure60.2%Gross margin, Q3 FY2025, three months to 2025-09-30. gross profit / revenueGross profit: $3.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-13, accession 0001104659-25-110730.Revenue: $5.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-13, accession 0001104659-25-110730.Report this figure53.6%Gross margin, Q4 FY2025, three months to 2025-12-31. gross profit / revenueGross profit: $2.8m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-19, accession 0001104659-26-031621. Derived: 12-month figure less the 9-month figure.Revenue: $5.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-03-19, accession 0001104659-26-031621. Derived: 12-month figure less the 9-month figure.Report this figure57.3%Gross margin, Q1 FY2026, three months to 2026-03-31. gross profit / revenueGross profit: $3.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-13, accession 0001104659-26-059676.Revenue: $5.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-13, accession 0001104659-26-059676.Report this figure61.7%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $3.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-11, accession 0001104659-26-093645.Revenue: $5.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-11, accession 0001104659-26-093645.Report this figure
Operating margin%(162.1%)Operating margin, Q3 FY2024, three months to 2024-09-30. operating income / revenueOperating income: −$12.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001104659-25-110730.Revenue: $7.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-13, accession 0001104659-25-110730.Report this figure(153.4%)Operating margin, Q4 FY2024, three months to 2024-12-31. operating income / revenueOperating income: −$11.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-19, accession 0001104659-26-031621. Derived: 12-month figure less the 9-month figure.Revenue: $7.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-03-19, accession 0001104659-26-031621. Derived: 12-month figure less the 9-month figure.Report this figure(139.4%)Operating margin, Q1 FY2025, three months to 2025-03-31. operating income / revenueOperating income: −$9.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001104659-26-059676.Revenue: $6.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-13, accession 0001104659-26-059676.Report this figure(171.4%)Operating margin, Q2 FY2025, three months to 2025-06-30. operating income / revenueOperating income: −$9.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001104659-26-093645.Revenue: $5.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-11, accession 0001104659-26-093645.Report this figure(189.4%)Operating margin, Q3 FY2025, three months to 2025-09-30. operating income / revenueOperating income: −$9.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001104659-25-110730.Revenue: $5.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-13, accession 0001104659-25-110730.Report this figure(163.7%)Operating margin, Q4 FY2025, three months to 2025-12-31. operating income / revenueOperating income: −$8.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-19, accession 0001104659-26-031621. Derived: 12-month figure less the 9-month figure.Revenue: $5.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-03-19, accession 0001104659-26-031621. Derived: 12-month figure less the 9-month figure.Report this figure(130.9%)Operating margin, Q1 FY2026, three months to 2026-03-31. operating income / revenueOperating income: −$7.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001104659-26-059676.Revenue: $5.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-13, accession 0001104659-26-059676.Report this figure(125.1%)Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$6.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001104659-26-093645.Revenue: $5.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-11, accession 0001104659-26-093645.Report this figure
Net margin%(166.1%)Net margin, Q3 FY2024, three months to 2024-09-30. net income / revenueNet income: −$12.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001104659-25-110730.Revenue: $7.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-13, accession 0001104659-25-110730.Report this figure(126.7%)Net margin, Q4 FY2024, three months to 2024-12-31. net income / revenueNet income: −$9.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-19, accession 0001104659-26-031621. Derived: 12-month figure less the 9-month figure.Revenue: $7.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-03-19, accession 0001104659-26-031621. Derived: 12-month figure less the 9-month figure.Report this figure(136.7%)Net margin, Q1 FY2025, three months to 2025-03-31. net income / revenueNet income: −$9.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-13, accession 0001104659-26-059676.Revenue: $6.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-13, accession 0001104659-26-059676.Report this figure(241.9%)Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: −$13.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001104659-26-093645.Revenue: $5.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-11, accession 0001104659-26-093645.Report this figure(209.0%)Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: −$10.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001104659-25-110730.Revenue: $5.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-13, accession 0001104659-25-110730.Report this figure(172.6%)Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: −$9.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-19, accession 0001104659-26-031621. Derived: 12-month figure less the 9-month figure.Revenue: $5.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-03-19, accession 0001104659-26-031621. Derived: 12-month figure less the 9-month figure.Report this figure(147.7%)Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: −$8.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-13, accession 0001104659-26-059676.Revenue: $5.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-13, accession 0001104659-26-059676.Report this figure(153.1%)Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: −$7.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001104659-26-093645.Revenue: $5.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-11, accession 0001104659-26-093645.Report this figure
Diluted EPS$ per share4.91Diluted EPS, Q3 FY2024, three months to 2024-09-30$4.91 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001104659-25-110730.Report this figurenot reported (Diluted EPS not reported)2.87Diluted EPS, Q1 FY2025, three months to 2025-03-31$2.87 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001104659-26-059676.Report this figure3.54Diluted EPS, Q2 FY2025, three months to 2025-06-30$3.54 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001104659-26-093645.Report this figure2.96Diluted EPS, Q3 FY2025, three months to 2025-09-30$2.96 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001104659-25-110730.Report this figurenot reported (Diluted EPS not reported)1.25Diluted EPS, Q1 FY2026, three months to 2026-03-31$1.25 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001104659-26-059676.Report this figure0.85Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.85 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001104659-26-093645.Report this figure
Free cash flow$k(7,389)Free cash flow, Q3 FY2024, three months to 2024-09-30. operating cash flow − capital expenditureOperating cash flow: −$7.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001104659-25-110730. Derived: 9-month figure less the 6-month figure.Capital expenditure: $32.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-13, accession 0001104659-25-110730. Derived: 9-month figure less the 6-month figure.Report this figure(6,753)Free cash flow, Q4 FY2024, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: −$6.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-19, accession 0001104659-26-031621. Derived: 12-month figure less the 9-month figure.Capital expenditure: $21.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-19, accession 0001104659-26-031621. Derived: 12-month figure less the 9-month figure.Report this figure(6,704)Free cash flow, Q1 FY2025, three months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: −$6.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001104659-26-059676.Capital expenditure: $31.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001104659-26-059676.Report this figure(6,075)Free cash flow, Q2 FY2025, three months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: −$6.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001104659-26-093645. Derived: 6-month figure less the 3-month figure.Capital expenditure: $44.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-11, accession 0001104659-26-093645. Derived: 6-month figure less the 3-month figure.Report this figure(7,391)Free cash flow, Q3 FY2025, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: −$7.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001104659-25-110730. Derived: 9-month figure less the 6-month figure.Capital expenditure: $41.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-13, accession 0001104659-25-110730. Derived: 9-month figure less the 6-month figure.Report this figure(5,913)Free cash flow, Q4 FY2025, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: −$5.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-19, accession 0001104659-26-031621. Derived: 12-month figure less the 9-month figure.Capital expenditure: $26.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-19, accession 0001104659-26-031621. Derived: 12-month figure less the 9-month figure.Report this figure(6,056)Free cash flow, Q1 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: −$6.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001104659-26-059676.Capital expenditure: $31.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001104659-26-059676.Report this figure(6,121)Free cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: −$6.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001104659-26-093645. Derived: 6-month figure less the 3-month figure.Capital expenditure: $38.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-11, accession 0001104659-26-093645. Derived: 6-month figure less the 3-month figure.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$22.4mGross margin 56.6%
Diluted EPS$10.12, FY2025
Free cash flow−$26.1m, FY2025
DarioHealth Corp., key figures for the last five fiscal years
Line itemUnitFY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31Shape over the periods
Revenue$m20.5Revenue, FY2021, twelve months to 2021-12-31$20.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2023-03-09, accession 0001558370-23-003240.Report this figure27.7Revenue, FY2022, twelve months to 2022-12-31$27.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2024-03-28, accession 0001558370-24-004151.Report this figure20.4Revenue, FY2023, twelve months to 2023-12-31$20.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2025-03-10, accession 0001558370-25-002527.Report this figure27.0Revenue, FY2024, twelve months to 2024-12-31$27.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-03-19, accession 0001104659-26-031621.Report this figure22.4Revenue, FY2025, twelve months to 2025-12-31$22.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-03-19, accession 0001104659-26-031621.Report this figure
Gross margin%19.3%Gross margin, FY2021, twelve months to 2021-12-31. gross profit / revenueGross profit: $4.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2023-03-09, accession 0001558370-23-003240.Revenue: $20.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2023-03-09, accession 0001558370-23-003240.Report this figure34.9%Gross margin, FY2022, twelve months to 2022-12-31. gross profit / revenueGross profit: $9.7m. XBRL concept us-gaap:GrossProfit. 10-K filed 2024-03-28, accession 0001558370-24-004151.Revenue: $27.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2024-03-28, accession 0001558370-24-004151.Report this figure29.4%Gross margin, FY2023, twelve months to 2023-12-31. gross profit / revenueGross profit: $6.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-03-10, accession 0001558370-25-002527.Revenue: $20.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2025-03-10, accession 0001558370-25-002527.Report this figure49.1%Gross margin, FY2024, twelve months to 2024-12-31. gross profit / revenueGross profit: $13.3m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-19, accession 0001104659-26-031621.Revenue: $27.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-03-19, accession 0001104659-26-031621.Report this figure56.6%Gross margin, FY2025, twelve months to 2025-12-31. gross profit / revenueGross profit: $12.7m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-19, accession 0001104659-26-031621.Revenue: $22.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-03-19, accession 0001104659-26-031621.Report this figure
Operating margin%(372.9%)Operating margin, FY2021, twelve months to 2021-12-31. operating income / revenueOperating income: −$76.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2023-03-09, accession 0001558370-23-003240.Revenue: $20.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2023-03-09, accession 0001558370-23-003240.Report this figure(205.4%)Operating margin, FY2022, twelve months to 2022-12-31. operating income / revenueOperating income: −$56.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-03-28, accession 0001558370-24-004151.Revenue: $27.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2024-03-28, accession 0001558370-24-004151.Report this figure(276.1%)Operating margin, FY2023, twelve months to 2023-12-31. operating income / revenueOperating income: −$56.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-10, accession 0001558370-25-002527.Revenue: $20.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2025-03-10, accession 0001558370-25-002527.Report this figure(213.6%)Operating margin, FY2024, twelve months to 2024-12-31. operating income / revenueOperating income: −$57.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-19, accession 0001104659-26-031621.Revenue: $27.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-03-19, accession 0001104659-26-031621.Report this figure(163.9%)Operating margin, FY2025, twelve months to 2025-12-31. operating income / revenueOperating income: −$36.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-19, accession 0001104659-26-031621.Revenue: $22.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-03-19, accession 0001104659-26-031621.Report this figure
Net margin%(374.2%)Net margin, FY2021, twelve months to 2021-12-31. net income / revenueNet income: −$76.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2023-03-09, accession 0001558370-23-003240.Revenue: $20.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2023-03-09, accession 0001558370-23-003240.Report this figure(224.9%)Net margin, FY2022, twelve months to 2022-12-31. net income / revenueNet income: −$62.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-03-28, accession 0001558370-24-004151.Revenue: $27.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2024-03-28, accession 0001558370-24-004151.Report this figure(292.0%)Net margin, FY2023, twelve months to 2023-12-31. net income / revenueNet income: −$59.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-10, accession 0001558370-25-002527.Revenue: $20.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2025-03-10, accession 0001558370-25-002527.Report this figure(158.1%)Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: −$42.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-19, accession 0001104659-26-031621.Revenue: $27.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-03-19, accession 0001104659-26-031621.Report this figure(186.6%)Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: −$41.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-19, accession 0001104659-26-031621.Revenue: $22.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-03-19, accession 0001104659-26-031621.Report this figure
Diluted EPS$ per share4.07Diluted EPS, FY2021, twelve months to 2021-12-31$4.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2023-03-09, accession 0001558370-23-003240.Report this figure2.54Diluted EPS, FY2022, twelve months to 2022-12-31$2.54 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-03-28, accession 0001558370-24-004151.Report this figure1.93Diluted EPS, FY2023, twelve months to 2023-12-31$1.93 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-03-10, accession 0001558370-25-002527.Report this figure12.27Diluted EPS, FY2024, twelve months to 2024-12-31$12.27 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-19, accession 0001104659-26-031621.Report this figure10.12Diluted EPS, FY2025, twelve months to 2025-12-31$10.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-19, accession 0001104659-26-031621.Report this figure
Free cash flow$m(50.7)Free cash flow, FY2021, twelve months to 2021-12-31. operating cash flow − capital expenditureOperating cash flow: −$50.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2023-03-09, accession 0001558370-23-003240.Capital expenditure: $261.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2023-03-09, accession 0001558370-23-003240.Report this figure(48.3)Free cash flow, FY2022, twelve months to 2022-12-31. operating cash flow − capital expenditureOperating cash flow: −$47.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-03-28, accession 0001558370-24-004151.Capital expenditure: $442.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-03-28, accession 0001558370-24-004151.Report this figure(31.0)Free cash flow, FY2023, twelve months to 2023-12-31. operating cash flow − capital expenditureOperating cash flow: −$30.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-10, accession 0001558370-25-002527.Capital expenditure: $584.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-10, accession 0001558370-25-002527.Report this figure(38.7)Free cash flow, FY2024, twelve months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: −$38.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-19, accession 0001104659-26-031621.Capital expenditure: $138.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-19, accession 0001104659-26-031621.Report this figure(26.1)Free cash flow, FY2025, twelve months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: −$25.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-19, accession 0001104659-26-031621.Capital expenditure: $142.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-19, accession 0001104659-26-031621.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding DarioHealth Corp.
FundQuarter endedReported valueSharesPut or callChange on the quarter before
Nantahala Capital Management, LLC2026-06-30$4.0m610,691Added+1
Nantahala Capital Management, LLC2026-06-30$4.0m610,691Added+1
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$433.5k65,675Reduced−235
GEODE CAPITAL MANAGEMENT, LLC2026-06-30$383.3k58,035Reduced−3,843
BlackRock, Inc.2026-06-30$249.5k37,796Added+18,978
VANGUARD FIDUCIARY TRUST CO2026-06-30$246.8k37,387Added+7,317
CITADEL ADVISORS LLC2026-06-30$160.3k24,289Added+3,829
NORTHERN TRUST CORP2026-06-30$87.4k13,237Unchanged
Vanguard Global Advisers, LLC2026-06-30$21.9k3,321Unchanged
MORGAN STANLEY2026-06-30$19.8k3,000Added+2,000

Recent filings

All 903 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

DarioHealth Corp., recent filings
FiledFormWhat it isAccession number
2026-09-0416:05 ET8-K5.02 Departure or appointment of officers or directors0001104659-26-105495
2026-08-2116:05 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001104659-26-099678
2026-08-1106:05 ET10-QQuarterly reportPeriod 2026-06-300001104659-26-093645
2026-07-2217:19 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-26-085900
2026-07-1017:10 ET8-K5.02 Departure or appointment of officers or directors0001104659-26-082715
2026-05-1306:05 ET10-QQuarterly reportPeriod 2026-03-310001104659-26-059676
2026-04-1308:21 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-26-042362
2026-03-3017:31 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001104659-26-036834
2026-03-1906:05 ET10-KAnnual reportPeriod 2025-12-310001104659-26-031621
2026-02-0216:32 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001104659-26-009247

Latest annual report

Form 10-K for the fiscal year ended Dec 31, 2025Filed Mar 19, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by [object Promise].Forecast this quarter

About the filer

CIK
1533998
Tickers
DRIO
Exchange
Nasdaq
SIC code
3841 Surgical & Medical Instruments & Apparatus
Sector
Healthcare
Fiscal year ends
Dec 31
Incorporated in
DE
Filer category
Non-accelerated filer<br>Smaller reporting company
Former names
LabStyle Innovations Corp. (to 2016-07-27)

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:42 ET. Listed shows no prices and gives no investment advice.